ANGIOTECH PHARMACEUTICALS INC Research and Development Expense
ANGIOTECH PHARMACEUTICALS INC reported Research and Development Expense of $7.06 million for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-28.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2013-03-28
- ANGIOTECH PHARMACEUTICALS INC research and development expense for the quarter ending 2012-12-31 was $1.25M.
- ANGIOTECH PHARMACEUTICALS INC research and development expense for the quarter ending 2012-09-30 was $1.40M, a 69.68% decline year-over-year.
- ANGIOTECH PHARMACEUTICALS INC research and development expense for the quarter ending 2012-06-30 was $2.42M.
- ANGIOTECH PHARMACEUTICALS INC research and development expense for the quarter ending 2012-03-31 was $1.99M.
- ANGIOTECH PHARMACEUTICALS INC research and development expense for fiscal 2012 was $7.06M.
| Period end | Research and Development Expense 2 month | Research and Development Expense 3 month | Research and Development Expense 5 month | Research and Development Expense 6 month | Research and Development Expense 8 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|---|---|---|
| 2012-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $2.65M derived: sum of 2 quarters · filed 2013-03-28 | $5.07M derived: sum of 3 quarters · filed 2013-03-28 | $7.06M 10-K · filed 2013-03-28 | |||
| 2012-09-30 | $1.40M 10-Q · filed 2012-11-14 | $3.82M derived: sum of 2 quarters · filed 2012-11-14 | $5.81M 10-Q · filed 2012-11-14 | ||||
| 2012-06-30 | $2.42M 10-Q/A · filed 2012-09-13 | $4.41M 10-Q/A · filed 2012-09-13 | |||||
| 2012-03-31 | $1.99M 10-Q · filed 2012-05-15 | ||||||
| 2011-12-31 | $14.08M 10-K · filed 2013-03-28 | ||||||
| 2011-09-30 | $4.61M 10-Q · filed 2012-11-14 | $7.44M 10-Q · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | ||||
| 2011-06-30 | $2.83M 10-Q/A · filed 2012-09-13 |